DSGN - CIK 0001807120
Design Therapeutics, Inc. (DSGN) reported revenue of $0.00 for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $0.00 | - |
| FY 2024 | $0.00 | -100.0% |
| FY 2020 | $226.00K | - |
Design Therapeutics, Inc. (DSGN) reported revenue of $0.00 for fiscal year 2025, as filed in its audited annual report with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.